U.S. federal trademark · Serial No. 86069080
Production and product commercialization for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
Discovery, research, development, engineering and testing of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Providing medical and scientific research information relating to pharmaceutical substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.